Drugs such as Mounjaro, Ozempic and Wegovy could reportedly become available at pharmacies for £9.90 after over-the-counter ...

It has been reported that pharmacies are "ready and able" to offer weight loss jabs on the NHS at a prescription price of ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...

CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its ...

With Wegovy in its portfolio, Novo Nordisk is a very good bet to continue being a winner. As it's currently considered something of an underdog, with its stock priced accordingly, it's also trading at ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli ...

But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...